Archive: 29/04/2022

download25

JelikaLite Awarded NSF SBIR Phase 1 Grant for EEG-Guided Intelligent Transcranial Photobiomodulation to Reduce Symptoms of Autism

We are thrilled to announce that client, JelikaLite, was awarded a National Science Foundation grant SBIR Phase 1: "EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism".   This new $256K grant will allow us to continue developing Cognilum, an non-invasive therapeuti...
JelikaLite Awarded NSF SBIR Phase 1 Grant for EEG-Guided Intelligent Transcranial Photobiomodulation to Reduce Symptoms of Autism